No takes yet. Share an insight, caveat, or question.
Review demonstrates improved postprandial glucose control with faster aspart in diabetes, indicating potential advantages over standard rapid-acting analogs.
Concetta Irace (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: